234 related articles for article (PubMed ID: 33122711)
1. Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy.
Minamikawa T; Ichimura-Shimizu M; Takanari H; Morimoto Y; Shiomi R; Tanioka H; Hase E; Yasui T; Tsuneyama K
Sci Rep; 2020 Oct; 10(1):18548. PubMed ID: 33122711
[TBL] [Abstract][Full Text] [Related]
2. Raman spectroscopy analysis of lipid droplets content, distribution and saturation level in Non-Alcoholic Fatty Liver Disease in mice.
Kochan K; Maslak E; Krafft C; Kostogrys R; Chlopicki S; Baranska M
J Biophotonics; 2015 Jul; 8(7):597-609. PubMed ID: 25346221
[TBL] [Abstract][Full Text] [Related]
3. Raman spectroscopy-based insight into lipid droplets presence and contents in liver sinusoidal endothelial cells and hepatocytes.
Szafraniec E; Kus E; Wislocka A; Kukla B; Sierka E; Untereiner V; Sockalingum GD; Chlopicki S; Baranska M
J Biophotonics; 2019 Apr; 12(4):e201800290. PubMed ID: 30578586
[TBL] [Abstract][Full Text] [Related]
4. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
Mashek DG
Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
[TBL] [Abstract][Full Text] [Related]
5. Mapping the triglyceride distribution in NAFLD human liver by MALDI imaging mass spectrometry reveals molecular differences in micro and macro steatosis.
Alamri H; Patterson NH; Yang E; Zoroquiain P; Lazaris A; Chaurand P; Metrakos P
Anal Bioanal Chem; 2019 Feb; 411(4):885-894. PubMed ID: 30515538
[TBL] [Abstract][Full Text] [Related]
6. Biomechanics of cultured hepatic cells during different steatogenic hits.
Baldini F; Bartolozzi A; Ardito M; Voci A; Portincasa P; Vassalli M; Vergani L
J Mech Behav Biomed Mater; 2019 Sep; 97():296-305. PubMed ID: 31151002
[TBL] [Abstract][Full Text] [Related]
7. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
[TBL] [Abstract][Full Text] [Related]
8. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.
Grasselli E; Canesi L; Portincasa P; Voci A; Vergani L; Demori I
Ann Hepatol; 2017; 16(5):707-719. PubMed ID: 28809727
[TBL] [Abstract][Full Text] [Related]
9. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis.
Gunn PJ; Pramfalk C; Millar V; Cornfield T; Hutchinson M; Johnson EM; Nagarajan SR; Troncoso-Rey P; Mithen RF; Pinnick KE; Traka MH; Green CJ; Hodson L
Physiol Rep; 2020 Jul; 8(13):e14482. PubMed ID: 32643289
[TBL] [Abstract][Full Text] [Related]
10. Label-free imaging and analysis of the effects of lipolysis products on primary hepatocytes.
Schie IW; Wu J; Weeks T; Zern MA; Rutledge JC; Huser T
J Biophotonics; 2011 Jun; 4(6):425-34. PubMed ID: 20878906
[TBL] [Abstract][Full Text] [Related]
11. Label-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopy.
Le TT; Ziemba A; Urasaki Y; Brotman S; Pizzorno G
PLoS One; 2012; 7(11):e51092. PubMed ID: 23226469
[TBL] [Abstract][Full Text] [Related]
12. Differential response of liver sinusoidal endothelial cells and hepatocytes to oleic and palmitic acid revealed by Raman and CARS imaging.
Matuszyk E; Sierka E; Rodewald M; Bae H; Meyer T; Kus E; Chlopicki S; Schmitt M; Popp J; Baranska M
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165763. PubMed ID: 32169502
[TBL] [Abstract][Full Text] [Related]
13. A new perspective on NAFLD: Focusing on lipid droplets.
Scorletti E; Carr RM
J Hepatol; 2022 Apr; 76(4):934-945. PubMed ID: 34793866
[TBL] [Abstract][Full Text] [Related]
14. Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis.
Vergani L
Curr Med Chem; 2019; 26(19):3439-3456. PubMed ID: 28521680
[TBL] [Abstract][Full Text] [Related]
15. Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.
Yoo W; Gjuka D; Stevenson HL; Song X; Shen H; Yoo SY; Wang J; Fallon M; Ioannou GN; Harrison SA; Beretta L
PLoS One; 2017; 12(12):e0189965. PubMed ID: 29244873
[TBL] [Abstract][Full Text] [Related]
16. Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease.
Kawano Y; Nishiumi S; Saito M; Yano Y; Azuma T; Yoshida M
Curr Drug Targets; 2015; 16(12):1293-300. PubMed ID: 25850622
[TBL] [Abstract][Full Text] [Related]
17. Raman imaging providing insights into chemical composition of lipid droplets of different size and origin: in hepatocytes and endothelium.
Majzner K; Kochan K; Kachamakova-Trojanowska N; Maslak E; Chlopicki S; Baranska M
Anal Chem; 2014 Jul; 86(13):6666-74. PubMed ID: 24936891
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
19. A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver.
Preuss C; Jelenik T; Bódis K; Müssig K; Burkart V; Szendroedi J; Roden M; Markgraf DF
Cells; 2019 Mar; 8(3):. PubMed ID: 30909521
[TBL] [Abstract][Full Text] [Related]
20. Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis.
Yokomori H; Ando W
BMJ Open Gastroenterol; 2020 May; 7(1):. PubMed ID: 32414752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
